Nanoscale metal-organic frameworks regulate redox homeostasis for Cancer therapy

Area of Science:

• Nanomedicine
• Redox Biology
• Materials Science

Background:

• Redox metabolism is crucial in cancer development and treatment resistance.
• Nanoscale metal-organic frameworks (MOFs) are promising for redox modulation due to their tunable properties and therapeutic delivery capabilities.

Purpose of the Study:

• To review recent advancements in MOF-based strategies for modulating tumor redox metabolism.
• To explore MOF applications in enhancing reactive oxygen species, suppressing antioxidant systems, and targeting redox signaling pathways.

Main Methods:

• Summarizing recent research on MOF-based redox modulation in cancer.
• Discussing strategies involving external stimuli, catalysis, and suppression of antioxidant systems (glutathione, thioredoxin, NAD(P)H).
• Analyzing MOF integration for controlled therapeutic agent release and modulation of redox-related signaling.

Main Results:

• MOFs can be designed with redox-active components to directly influence cellular redox processes.
• MOFs facilitate efficient loading and controlled release of therapeutic agents for enhanced anti-cancer effects.
• MOF-based strategies show potential in increasing reactive oxygen species and inhibiting key antioxidant systems.

Conclusions:

• MOF-based nanomedicine presents a versatile platform for targeting tumor redox biology.
• Key challenges include ensuring biosafety, stability, and facilitating clinical translation of MOF-based therapies.
• Future research should focus on the intersection of MOF design and tumor redox biology for improved cancer treatment.